Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Healthy Extracts (HYEX) Notes Payables (2016 - 2025)

Healthy Extracts filings provide 10 years of Notes Payables readings, the most recent being $111330.0 for Q4 2025.

  • On a quarterly basis, Notes Payables rose 4487.14% to $111330.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $111330.0, a 4487.14% increase, with the full-year FY2025 number at $111330.0, up 4487.14% from a year prior.
  • Notes Payables hit $111330.0 in Q4 2025 for Healthy Extracts, up from $110613.0 in the prior quarter.
  • In the past five years, Notes Payables ranged from a high of $864750.0 in Q3 2021 to a low of $2427.0 in Q4 2024.
  • Median Notes Payables over the past 5 years was $346750.0 (2021), compared with a mean of $347385.6.
  • Biggest five-year swings in Notes Payables: skyrocketed 12711.11% in 2021 and later crashed 99.33% in 2024.
  • Healthy Extracts' Notes Payables stood at $171750.0 in 2021, then surged by 84.74% to $317284.0 in 2022, then grew by 13.81% to $361093.0 in 2023, then crashed by 99.33% to $2427.0 in 2024, then surged by 4487.14% to $111330.0 in 2025.
  • The last three reported values for Notes Payables were $111330.0 (Q4 2025), $110613.0 (Q3 2025), and $155264.0 (Q2 2025) per Business Quant data.